A Study to Compare MitoQ and Placebo to Treat Non-alcoholic Fatty Liver Disease (NAFLD)

NCT01167088 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

110

Enrollment

INDUSTRY

Sponsor class

Stopped This study has been terminated due to poor participant recruitment

Conditions

Non-alcoholic Fatty Liver Disease

Interventions

DRUG: Mitoquinone mesylate
DRUG: Placebo

Sponsor

Antipodean Pharmaceuticals, Inc.